Thiamine Pyrophosphate and Pyridoxamine Inhibit the Formation of Antigenic Advanced Glycation End-Products: Comparison with Aminoguanidine
- 1 March 1996
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 220 (1), 113-119
- https://doi.org/10.1006/bbrc.1996.0366
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.Proceedings of the National Academy of Sciences, 1994
- Glycation and Diabetic ComplicationsDiabetes, 1994
- Production and characterization of antibodies to advanced glycation products on proteinsBiochemical and Biophysical Research Communications, 1989
- Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageingBiochemical Journal, 1988
- Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylationLife Sciences, 1988
- Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-LinkingScience, 1986
- Glycosyl albumin and diabetic microalbuminuria: Demonstration of an altered renal handlingKidney International, 1984
- Reaction of Monosaccharides with Proteins: Possible Evolutionary SignificanceScience, 1981
- PRODUCTION OF PSEUDODIABETIC RENAL GLOMERULAR CHANGES IN MICE AFTER REPEATED INJECTIONS OF GLUCOSYLATED PROTEINSThe Lancet, 1980
- Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus.Proceedings of the National Academy of Sciences, 1979